(PharmaNewsWire.Com, January 14, 2017 ) latest Pharmaceutical and Healthcare disease pipeline guide Treatment Resistant Depression - Pipeline Review, H2 2016, provides an overview of the Treatment Resistant Depression (Central Nervous System) pipeline landscape.
Treatment resistant depression (TRD) is an episode of major depressive disorder that does not respond to an antidepressant medication. Symptoms include difficulty concentrating, fatigue, insomnia, overeating or appetite loss and persistent aches or pains, headaches, cramps, or digestive problems. Treatment includes antidepressant from a different drug class, antipsychotic medication, electroconvulsive therapy (ECT) and vagus nerve stimulation.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Treatment Resistant Depression - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Treatment Resistant Depression (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. For more information about this report at http://www.reportsweb.com/biobanking-developing-smart-sustainable-and-ethically-compliant-biorepositories-for-the-future Scope
- What are the fundamentals of biobanking? - How can biobanks be classified and what are their different applications in healthcare? - What are the economic challenges faced by biobanks and how can these be overcome? - What are the most recent technology advancements in biobanking? - What role does biobanking play in drug discovery and clinical trials? - How are biobanks distributed geographically? - What are the prospects of Big Data and associated technologies within biobanking? - What are the technological and legal challenges? - What are the main healthcare opportunities that can be leveraged? - What is the public attitude towards various biobanking activities? - What are the challenges in obtaining informed consent from donors and what strategies can biobanks adopt to overcome these challenges? - What are the current ethical and regulatory challenges in biobanking?
Key Reasons to Purchase
This report will allow you to - - Gain insights in the biobanking industry: This report describes fundamental concepts in biobanking, biobank classification as well as economic, technological and ethical challenges surrounding these organizations. Learn how biobanks can overcome these challenges through best practice guidelines and strategic recommendations. - Understand the role of biobanks in research and development: This report demonstrates the relationship between biobanks and R&D groups. - Gain analysis on the distribution of biobanks in key regions and countries: This includes detailed analysis on the number of biobanks within each of the key regions and countries. - Review and assess recent advances in biobanking technologies: This includes technology innovations in specimen collection, storage, temperature maintenance, consumables, data handling, transportation of biospecimens, and the integration of big data technologies in biobanking activities. - Understand public views on biobanking activities: Learn about the various public concerns on biobanking, their attitude towards research, and how consent issues can be addressed through novel frameworks and technology adoption. - Assess ethics, regulations, and harmonization needs in biobanking: This in-depth report provides analysis on ethical, regulatory and harmonization requirements in the biobanking sector.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001170008/sample Tables of Content: Introduction Fundamentals of Biobanking Designing Biobanks Classification of Biobanks Applications of Biobanks Economic Challenges faced by Biobanks Cost-Control Strategies for Biobanks Cost-Recovery Strategies for Biobanks Funding Models and Recommendations for Biobanks Biobank Characterization by Type Population-based Biobanks Disease-Based Biobanks Biobanks Based on Type of Sample Collections Role of Biobanks in Drug Discovery and Development Biobanking and Clinical Trials Regional Presence of Biobanks Selected Biobank Profiles Advances in Biobanking Technologies and Solutions Specimen Collection and Storage Transport of Specimens Data Handling Software Big Data Current Technological, Ethical and Legal challenges Big Data Opportunities in Healthcare Integration of Big Data Technologies Public Attitudes Towards Biobanking Informed consent challenges Informed Consent Strategies for Biobanks Ethics and Regulations in Biobanking Current Challenges Ask for Discount at http://www.reportsweb.com/inquiry&RW0001170008/discount
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
